Rx Import Plan Would Require Funds To Inspect All U.S. Pharmacies – FDA
Executive Summary
Prescription drug importation legislation would need to provide FDA with enough funding to inspect all 55,000 pharmacies in the U.S., FDA Pharmacy Affairs Director Tom McGinnis told a Washington Legal Foundation briefing June 15 in Washington, D.C
You may also be interested in...
Dorgan/Kennedy Bill Would Allow Importation Of Some Biologics
The drug importation bill put forward by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) allows for the importation of subcutaneous biologics approved as NDAs
Dorgan/Kennedy Bill Would Allow Importation Of Some Biologics
The drug importation bill put forward by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) allows for the importation of subcutaneous biologics approved as NDAs
Senate Drug Import Bill Would Require Notice Of Manufacturing Changes
Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21